
HTG Molecular Diagnostics HTGM
Annual report 2022
added 03-30-2023
HTG Molecular Diagnostics EBITDA per Share 2011-2026 | HTGM
Annual EBITDA per Share HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.8 | -29.6 | -3.94 | -6.78 | -8.01 | -23.3 | -48.2 | -60.5 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.94 | -60.5 | -25.4 |
Quarterly EBITDA per Share HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.38 | -0.5 | -0.76 | - | -0.54 | -0.58 | -0.73 | - | -1.01 | -1.05 | -1.17 | - | -0.14 | -0.15 | -0.18 | - | -0.16 | -0.13 | -0.2 | - | -0.41 | -0.53 | -0.64 | - | -0.81 | -0.85 | -0.92 | - | -0.68 | -1.15 | -11.5 | - | -28.7 | -34.6 | -27.3 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.13 | -34.6 | -4.29 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
5.49 | $ 120.47 | 1.2 % | $ 36.6 B | ||
|
Anixa Biosciences
ANIX
|
-361 | $ 2.9 | 2.47 % | $ 94.1 K | ||
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 22.13 | -5.98 % | $ 243 M | ||
|
Celcuity
CELC
|
-2.87 | $ 108.86 | 1.36 % | $ 4.29 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 27.97 | 1.43 % | $ 777 M | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 14.17 | 2.72 % | $ 428 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 179.12 | 1.95 % | $ 8.88 B | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
IDEXX Laboratories
IDXX
|
18.7 | $ 638.42 | 0.62 % | $ 51.3 B | ||
|
Illumina
ILMN
|
-3.01 | $ 131.73 | 1.67 % | $ 20.9 B | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 282.44 | -0.19 % | $ 23.5 B | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 79.34 | 0.63 % | $ 5.35 B | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
-0.22 | $ 15.04 | -2.97 % | $ 1.95 B | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Mettler-Toledo International
MTD
|
2.48 | $ 1 319.33 | 0.2 % | $ 27.2 B | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 5.43 | 2.65 % | $ 503 M | ||
|
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | ||
|
NeoGenomics
NEO
|
-0.62 | $ 9.65 | 1.1 % | $ 1.24 B | ||
|
BioNano Genomics
BNGO
|
-70.8 | $ 1.12 | - | $ 1.42 M | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 209.29 | 0.44 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
7.63 | $ 204.98 | 0.48 % | $ 146 B | ||
|
National Research Corporation
NRC
|
1.64 | $ 13.39 | - | $ 329 M | ||
|
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | $ 103.46 | 0.09 % | $ 19.5 B | ||
|
Bioventus
BVS
|
-0.39 | $ 8.57 | -1.95 % | $ 537 M | ||
|
OPKO Health
OPK
|
-0.08 | $ 1.21 | 1.68 % | $ 840 M | ||
|
DarioHealth Corp.
DRIO
|
-1.96 | $ 10.5 | 1.94 % | $ 298 M | ||
|
DexCom
DXCM
|
2.98 | $ 71.55 | -2.09 % | $ 27.9 B | ||
|
PerkinElmer
PKI
|
6.54 | - | -0.91 % | $ 14.7 B | ||
|
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.62 | 6.25 % | $ 486 M | ||
|
Psychemedics Corporation
PMD
|
-0.21 | - | -1.84 % | $ 15.3 M | ||
|
QIAGEN N.V.
QGEN
|
1.35 | - | - | $ 10.6 B | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 111.03 | 2.14 % | $ 9.16 B | ||
|
Quotient Limited
QTNT
|
-0.806 | - | -11.32 % | $ 1.1 M | ||
|
Precipio
PRPO
|
-4.93 | $ 25.4 | 1.7 % | $ 33 M | ||
|
Renalytix AI plc
RNLX
|
-0.27 | - | 5.66 % | $ 22.7 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 19.2 | 2.13 % | $ 1.02 B | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M |